Temozolomide Therapy for Aggressive Pituitary Tumors: Results in a Small Series of Patients from Argentina
出版年份 2015 全文链接
标题
Temozolomide Therapy for Aggressive Pituitary Tumors: Results in a Small Series of Patients from Argentina
作者
关键词
-
出版物
International Journal of Endocrinology
Volume 2015, Issue -, Pages 1-8
出版商
Hindawi Limited
发表日期
2015-05-28
DOI
10.1155/2015/587893
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Long-lasting complete remission after therapy with temozolomide in two patients with macrocorticotropinoma causing Cushing's disease
- (2015) Oscar D. Bruno et al. CLINICAL ENDOCRINOLOGY
- Long-Term Outcome and MGMT as a Predictive Marker in 24 Patients With Atypical Pituitary Adenomas and Pituitary Carcinomas Given Treatment With Temozolomide
- (2015) Daniel Bengtsson et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Temozolomide and pasireotide treatment for aggressive pituitary adenoma: expertise at a tertiary care center
- (2015) Filippo Ceccato et al. JOURNAL OF NEURO-ONCOLOGY
- Temozolomide retreatment in a recurrent prolactin-secreting pituitary adenoma: Hormonal and radiographic response
- (2015) RE Strowd et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- Non-uniform Response to Temozolomide Therapy in a Pituitary Gonadotroph Adenoma
- (2014) Ayca Ersen et al. CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES
- Effect of Temozolomide in a patient with recurring oncocytic gonadotrophic pituitary adenoma
- (2014) Luis Syro et al. Hormones-International Journal of Endocrinology and Metabolism
- Aggressive silent corticotroph adenoma progressing to pituitary carcinoma. The role of temozolomide therapy
- (2014) Olga Moshkin et al. Hormones-International Journal of Endocrinology and Metabolism
- What causes a prolactinoma to be aggressive or to become a pituitary carcinoma?
- (2014) Jana Phillips et al. Hormones-International Journal of Endocrinology and Metabolism
- Multiple Cerebral Hemorrhagic Foci From Metastases During Temozolomide Treatment in a Patient With Corticotroph Pituitary Carcinoma
- (2014) Marco Mendola et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Pituitary atypical adenoma or carcinoma sensitive to temozolomide combined with radiation therapy: a case report of early identification and management
- (2014) Zhong Chuanhong et al. Turkish Neurosurgery
- Activity of temozolomide in patients with advanced chemorefractory colorectal cancer and MGMT promoter methylation
- (2013) F. Pietrantonio et al. ANNALS OF ONCOLOGY
- Aggressive Silent GH Pituitary Tumor Resistant to Multiple Treatments, Including Temozolomide
- (2013) Marie Batisse et al. CANCER INVESTIGATION
- The Role of Temozolomide in the Treatment of a Patient with a Pure Silent Pituitary Somatotroph Carcinoma
- (2013) Leonardo Neto et al. Endocrine Practice
- DNA Mismatch Repair Protein (MSH6) Correlated With the Responses of Atypical Pituitary Adenomas and Pituitary Carcinomas to Temozolomide: The National Cooperative Study by the Japan Society for Hypothalamic and Pituitary Tumors
- (2013) Toshio Hirohata et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Molecular status of pituitary carcinoma and atypical adenoma that contributes the effectiveness of temozolomide
- (2013) Akira Matsuno et al. Medical Molecular Morphology
- High Response Rates and Prolonged Survival in Patients With Corticotroph Pituitary Tumors and Refractory Cushing Disease From Capecitabine and Temozolomide (CAPTEM)
- (2013) Brad E. Zacharia et al. NEUROSURGERY
- Long-term control of a MEN1 prolactin secreting pituitary carcinoma after temozolomide treatment
- (2012) Melanie Philippon et al. ANNALES D ENDOCRINOLOGIE
- Temozolomide in the management of dopamine agonist-resistant prolactinomas
- (2012) B. C. Whitelaw et al. CLINICAL ENDOCRINOLOGY
- Pituitary carcinoma recurrent to the lumbar intradural extramedullary space: Case report
- (2012) Paul M. Arnold et al. JOURNAL OF SPINAL CORD MEDICINE
- Aggressive pituitary tumours: the role of temozolomide and the assessment of MGMT status
- (2011) Ann I. McCormack et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Clinically silent somatotroph adenomas are common
- (2011) Alisha N Wade et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Therapy of aggressive pituitary tumors
- (2011) Annamaria Colao et al. EXPERT OPINION ON PHARMACOTHERAPY
- Pituitary Carcinoma: Difficult Diagnosis and Treatment
- (2011) Anthony P. Heaney JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- New targeted therapies in pituitary carcinoma resistant to temozolomide
- (2011) Emmanuel Jouanneau et al. Pituitary
- Temozolomide responsiveness in aggressive corticotroph tumours: a case report and review of the literature
- (2011) A. K. Annamalai et al. Pituitary
- Pituitary blastoma: a unique embryonal tumor
- (2011) Bernd W. Scheithauer et al. Pituitary
- Anti-VEGF therapy in pituitary carcinoma
- (2011) Leon D. Ortiz et al. Pituitary
- Temozolomide-Induced Shrinkage of a Pituitary Carcinoma Causing Cushing's Disease — Report of a Case and Literature Review
- (2011) Lorenzo Curtò et al. TheScientificWorldJOURNAL
- Salvage therapy with temozolomide in patients with aggressive or metastatic pituitary adenomas: experience in six cases
- (2010) Marco Losa et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- SOM230 (Pasireotide) and Temozolomide Achieve Sustained Control of Tumour Progression and ACTH Secretion in Pituitary Carcinoma with Widespread Metastases
- (2010) H. Bode et al. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
- Temozolomide Treatment for Aggressive Pituitary Tumors: Correlation of Clinical Outcome with O6-Methylguanine Methyltransferase (MGMT) Promoter Methylation and Expression
- (2010) Zachary M. Bush et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Temozolomide Treatment in Aggressive Pituitary Tumors and Pituitary Carcinomas: A French Multicenter Experience
- (2010) Gérald Raverot et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Atypical pituitary adenomas: incidence, clinical characteristics, and implications
- (2010) Gabriel Zada et al. JOURNAL OF NEUROSURGERY
- Failure of temozolomide and conventional doses of pegvisomant to attain biochemical control in a severe case of acromegaly
- (2010) Emilie Morin et al. Pituitary
- Temozolomide for corticotroph pituitary adenomas refractory to standard therapy
- (2010) Troy H. Dillard et al. Pituitary
- Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK)
- (2009) Alberto Fernandez et al. CLINICAL ENDOCRINOLOGY
- High incidence of low O6-methylguanine DNA methyltransferase expression in invasive macroadenomas of Cushing's disease
- (2009) Akira Takeshita et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Temozolomide treatment of a pituitary carcinoma and two pituitary macroadenomas resistant to conventional therapy
- (2009) C Hagen et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- USE OF TEMOZOLOMIDE IN AGGRESSIVE PITUITARY TUMORS
- (2009) Safraz Mohammed et al. NEUROSURGERY
- Temozolomide (Temodar®) and capecitabine (Xeloda®) treatment of an aggressive corticotroph pituitary tumor
- (2009) Marie S. Thearle et al. Pituitary
- Treatment of Nelson's syndrome with temozolomide
- (2008) V J Moyes et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started